Flexpharma Inc. (FLKS) Stock Price & Overview

NASDAQ:FLKS

Current stock price

0.6068
+0 (+0.23%)
At close:
0.55
-0.06 (-9.36%)
After Hours:

The current stock price of FLKS is 0.6068 null. Today FLKS is up by 0.23%. In the past month the price increased by 25.11%. In the past year, price decreased by -30.65%.

FLKS Key Statistics

52-Week Range0.26 - 1.49
Current FLKS stock price positioned within its 52-week range.
1-Month Range0.47 - 0.9779
Current FLKS stock price positioned within its 1-month range.
Market Cap
10.964M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.88
Dividend Yield
N/A

FLKS Stock Performance

Today
+0.23%
1 Week
-25.09%
1 Month
+25.11%
3 Months
+14.49%
Longer-term
6 Months +83.88%
1 Year -30.65%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

FLKS Stock Chart

Flexpharma Inc. / FLKS Daily stock chart

FLKS Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to FLKS. When comparing the yearly performance of all stocks, FLKS is a bad performer in the overall market: 69.29% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
FLKS Full Technical Analysis Report

FLKS Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to FLKS. The financial health of FLKS is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
FLKS Full Fundamental Analysis Report

FLKS Earnings

Next Earnings DateN/A
Last Earnings DateN/A
FLKS Earnings History

FLKS Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next Y54.92%
Revenue Next YearN/A
FLKS Forecast & Estimates

FLKS Financial Highlights

Over the last trailing twelve months FLKS reported a non-GAAP Earnings per Share(EPS) of -0.88. The EPS increased by 55.33% compared to the year before.


Income Statements
Revenue(TTM)683.80K
Net Income(TTM)-8.26M
Industry RankSector Rank
PM (TTM) -1208.29%
ROA -115.76%
ROE -135.42%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%73.91%
Sales Q2Q%-32.91%
EPS 1Y (TTM)55.33%
Revenue 1Y (TTM)-38.97%
FLKS financials

FLKS Ownership

Ownership
Inst Owners14.42%
Shares18.07M
Float15.41M
Ins Owners19.7%
Short Float %N/A
Short RatioN/A
FLKS Ownership

About FLKS

Company Profile

Flex Pharma, Inc. is a biotechnology company. The Company is involved in developing treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. Flex Pharma, Inc. is headquartered in Boston, Massachusetts.

Company Info

Flexpharma Inc.

31 St. James Avenue 6thFloor

Boston MA 02116

CEO: William McVicar

Phone: 617-874-1821

Flexpharma Inc. / FLKS FAQ

Can you describe the business of Flexpharma Inc.?

Flex Pharma, Inc. is a biotechnology company. The Company is involved in developing treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. Flex Pharma, Inc. is headquartered in Boston, Massachusetts.


What is the current price of FLKS stock?

The current stock price of FLKS is 0.6068 null. The price increased by 0.23% in the last trading session.


Does FLKS stock pay dividends?

FLKS does not pay a dividend.


What is the ChartMill rating of Flexpharma Inc. stock?

FLKS has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


On which exchange is FLKS stock listed?

FLKS stock is listed on the Nasdaq exchange.